Global Pain Management Drugs Market, 2021-2027
The global pain management drugs market is projected to grow at a compound annual growth rate (CAGR) of 4.56% during the forecast period 2021-2027, according to the new report published by Gen Consulting Company.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global pain management drugs market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, company share of market leaders, growth rate and market segments.
The pain management drugs market is segmented on the basis of drug class, and indication, and region. The pain management drugs market is segmented as below:
By Drug Class:
*list is not exhaustive, request free sample to get a complete list of companies
Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.
Scope of the Report
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global pain management drugs market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, company share of market leaders, growth rate and market segments.
The pain management drugs market is segmented on the basis of drug class, and indication, and region. The pain management drugs market is segmented as below:
By Drug Class:
- anesthetics
- anticonvulsant
- antidepressant drugs
- antimigraine drug
- non-narcotic analgesics
- NSAIDS
- opioids
- arthritic pain
- cancer pain
- chronic pain
- fibromyalgia
- migraine
- neuropathic pain
- post-operative pain
- region
- Asia-Pacific
- Europe
- North America
- Middle East and Africa (MEA)
- South America
*list is not exhaustive, request free sample to get a complete list of companies
Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global pain management drugs market.
- To classify and forecast the global pain management drugs market based on drug class, and indication, and region.
- To identify drivers and challenges for the global pain management drugs market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global pain management drugs market.
- To conduct pricing analysis for the global pain management drugs market.
- To identify and analyze the profile of leading players operating in the global pain management drugs market.
- Gain a reliable outlook of the global pain management drugs market forecasts from 2021 to 2027 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
PART 1. INTRODUCTION
1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment
PART 2. METHODOLOGY
2.1 Primary
2.2 Secondary
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic
PART 5. GLOBAL MARKET FOR PAIN MANAGEMENT DRUGS BY DRUG CLASS
5.1 Anesthetics
5.1.1 Market Size and Forecast
5.2 Anticonvulsant
5.2.1 Market Size and Forecast
5.3 Antidepressant Drugs
5.3.1 Market Size and Forecast
5.4 Antimigraine Drug
5.4.1 Market Size and Forecast
5.5 Non-Narcotic Analgesics
5.5.1 Market Size and Forecast
5.6 Nsaids
5.6.1 Market Size and Forecast
5.7 Opioids
5.7.1 Market Size and Forecast
PART 6. GLOBAL MARKET FOR PAIN MANAGEMENT DRUGS BY INDICATION
6.1 Arthritic Pain
6.1.1 Market Size and Forecast
6.2 Cancer Pain
6.2.1 Market Size and Forecast
6.3 Chronic Pain
6.3.1 Market Size and Forecast
6.4 Fibromyalgia
6.4.1 Market Size and Forecast
6.5 Migraine
6.5.1 Market Size and Forecast
6.6 Neuropathic Pain
6.6.1 Market Size and Forecast
6.7 Post-Operative Pain
6.7.1 Market Size and Forecast
PART 8. GLOBAL MARKET FOR PAIN MANAGEMENT DRUGS BY REGION
8.1 Asia-Pacific
8.1.1 Market Size and Forecast
8.2 Europe
8.2.1 Market Size and Forecast
8.3 North America
8.3.1 Market Size and Forecast
8.4 Middle East And Africa (Mea)
8.4.1 Market Size and Forecast
8.5 South America
8.5.1 Market Size and Forecast
PART 8. KEY COMPETITOR PROFILES
8.1 Abbott Laboratories
8.2 Eli Lily and Company
8.3 GlaxoSmithKline plc
8.4 Johnson & Johnson
8.5 Merck & Co.
8.6 Mylan N.V
8.7 Novartis International AG
8.8 Pfizer Inc.
8.9 Purdue Pharma L.P.
*LIST IS NOT EXHAUSTIVE
PART 9. PATENT ANALYSIS
9.1 Patent Statistics
9.2 Regional Analysis
9.3 Trends Analysis
DISCLAIMER
ABOUT GEN CONSULTING COMPANY
1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment
PART 2. METHODOLOGY
2.1 Primary
2.2 Secondary
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic
PART 5. GLOBAL MARKET FOR PAIN MANAGEMENT DRUGS BY DRUG CLASS
5.1 Anesthetics
5.1.1 Market Size and Forecast
5.2 Anticonvulsant
5.2.1 Market Size and Forecast
5.3 Antidepressant Drugs
5.3.1 Market Size and Forecast
5.4 Antimigraine Drug
5.4.1 Market Size and Forecast
5.5 Non-Narcotic Analgesics
5.5.1 Market Size and Forecast
5.6 Nsaids
5.6.1 Market Size and Forecast
5.7 Opioids
5.7.1 Market Size and Forecast
PART 6. GLOBAL MARKET FOR PAIN MANAGEMENT DRUGS BY INDICATION
6.1 Arthritic Pain
6.1.1 Market Size and Forecast
6.2 Cancer Pain
6.2.1 Market Size and Forecast
6.3 Chronic Pain
6.3.1 Market Size and Forecast
6.4 Fibromyalgia
6.4.1 Market Size and Forecast
6.5 Migraine
6.5.1 Market Size and Forecast
6.6 Neuropathic Pain
6.6.1 Market Size and Forecast
6.7 Post-Operative Pain
6.7.1 Market Size and Forecast
PART 8. GLOBAL MARKET FOR PAIN MANAGEMENT DRUGS BY REGION
8.1 Asia-Pacific
8.1.1 Market Size and Forecast
8.2 Europe
8.2.1 Market Size and Forecast
8.3 North America
8.3.1 Market Size and Forecast
8.4 Middle East And Africa (Mea)
8.4.1 Market Size and Forecast
8.5 South America
8.5.1 Market Size and Forecast
PART 8. KEY COMPETITOR PROFILES
8.1 Abbott Laboratories
8.2 Eli Lily and Company
8.3 GlaxoSmithKline plc
8.4 Johnson & Johnson
8.5 Merck & Co.
8.6 Mylan N.V
8.7 Novartis International AG
8.8 Pfizer Inc.
8.9 Purdue Pharma L.P.
*LIST IS NOT EXHAUSTIVE
PART 9. PATENT ANALYSIS
9.1 Patent Statistics
9.2 Regional Analysis
9.3 Trends Analysis
DISCLAIMER
ABOUT GEN CONSULTING COMPANY